RYAM Fundamental Analysis - RAYONIER ADVANCED MATERIALS

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to RYAM. RYAM was compared to 83 industry peers in the Chemicals industry. RYAM has a bad profitability rating. Also its financial health evaluation is rather negative. RYAM has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year RYAM has reported negative net income.

RYAM had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: RYAM reported negative net income in multiple years.

Each year in the past 5 years RYAM had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -25.28%, RYAM is not doing good in the industry: 86.75% of the companies in the same industry are doing better.

RYAM has a worse Return On Equity (-129.63%) than 87.95% of its industry peers.

RYAM has a worse Return On Invested Capital (1.20%) than 73.49% of its industry peers.

The Average Return On Invested Capital over the past 3 years for RYAM is below the industry average of 6.34%.

		Industry Rank	Sector Rank
ROA	-25.28%
ROE	-129.63%
ROIC	1.2%

ROA(3y)-2.37%

ROA(5y)-0.88%

ROE(3y)-6.96%

ROE(5y)-2.53%

ROIC(3y)1.78%

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.38%, RYAM is doing worse than 77.11% of the companies in the same industry.

RYAM has a Gross Margin of 8.44%. This is amonst the worse of the industry: RYAM underperforms 83.13% of its industry peers.

RYAM's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	1.38%
PM (TTM)	N/A
GM	8.44%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y24.16%

GM growth 5Y22.12%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RYAM is destroying value.

RYAM has more shares outstanding than it did 1 year ago.

The number of shares outstanding for RYAM has been increased compared to 5 years ago.

Compared to 1 year ago, RYAM has an improved debt to assets ratio.

2.2 Solvency

RYAM has an Altman-Z score of 1.17. This is a bad value and indicates that RYAM is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.17, RYAM is not doing good in the industry: 75.90% of the companies in the same industry are doing better.

A Debt/Equity ratio of 2.10 is on the high side and indicates that RYAM has dependencies on debt financing.

RYAM has a Debt to Equity ratio of 2.10. This is amonst the worse of the industry: RYAM underperforms 81.93% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.1
Debt/FCF	N/A
Altman-Z	1.17

ROIC/WACC0.1

WACC11.96%

2.3 Liquidity

RYAM has a Current Ratio of 1.45. This is a normal value and indicates that RYAM is financially healthy and should not expect problems in meeting its short term obligations.

RYAM's Current ratio of 1.45 is on the low side compared to the rest of the industry. RYAM is outperformed by 72.29% of its industry peers.

A Quick Ratio of 0.83 indicates that RYAM may have some problems paying its short term obligations.

With a Quick ratio value of 0.83, RYAM is not doing good in the industry: 80.72% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.45
Quick Ratio	0.83

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for RYAM have decreased strongly by -194.29% in the last year.

Looking at the last year, RYAM shows a decrease in Revenue. The Revenue has decreased by -4.90% in the last year.

The Revenue has been growing slightly by 2.64% on average over the past years.

EPS 1Y (TTM)-194.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-2978.95%

Revenue 1Y (TTM)-4.9%

Revenue growth 3Y5.02%

Revenue growth 5Y2.64%

Sales Q2Q%-18.27%

3.2 Future

The Earnings Per Share is expected to grow by 194.97% on average over the next years. This is a very strong growth

RYAM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.30% yearly.

EPS Next Y-8672%

EPS Next 2Y193.19%

EPS Next 3Y194.97%

EPS Next 5YN/A

Revenue Next Year-10.38%

Revenue Next 2Y-3.16%

Revenue Next 3Y0.3%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

RYAM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 20.83, the valuation of RYAM can be described as rather expensive.

RYAM's Price/Forward Earnings is on the same level as the industry average.

The average S&P500 Price/Forward Earnings ratio is at 22.89. RYAM is around the same levels.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	20.83

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RYAM indicates a somewhat cheap valuation: RYAM is cheaper than 77.11% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.38

4.3 Compensation for Growth

A more expensive valuation may be justified as RYAM's earnings are expected to grow with 194.97% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y193.19%

EPS Next 3Y194.97%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

RYAM does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

RAYONIER ADVANCED MATERIALS

NYSE:RYAM (9/26/2025, 8:04:00 PM)

After market: 6.87 0 (0%)

6.87

+0.13 (+1.93%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)08-05 2025-08-05/amc

Earnings (Next)11-03 2025-11-03/amc

Inst Owners71.63%

Inst Owner Change-6.81%

Ins Owners4.76%

Ins Owner Change5.12%

Market Cap460.29M

Analysts82.86

Price Target6.12 (-10.92%)

Short Float %1.92%

Short Ratio1.83

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-1499.57%

Min EPS beat(2)-2198.35%

Max EPS beat(2)-800.79%

EPS beat(4)1

Avg EPS beat(4)-751.28%

Min EPS beat(4)-2198.35%

Max EPS beat(4)47.48%

EPS beat(8)3

Avg EPS beat(8)-633.7%

EPS beat(12)5

Avg EPS beat(12)-407.34%

EPS beat(16)6

Avg EPS beat(16)-410.33%

Revenue beat(2)0

Avg Revenue beat(2)-12.29%

Min Revenue beat(2)-13.53%

Max Revenue beat(2)-11.06%

Revenue beat(4)0

Avg Revenue beat(4)-7.38%

Min Revenue beat(4)-13.53%

Max Revenue beat(4)-0.8%

Revenue beat(8)2

Avg Revenue beat(8)-5.85%

Revenue beat(12)5

Avg Revenue beat(12)-2.77%

Revenue beat(16)6

Avg Revenue beat(16)-2.87%

PT rev (1m)0%

PT rev (3m)-7.69%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-122.73%

EPS NY rev (1m)-616.67%

EPS NY rev (3m)-711.32%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-6.93%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-6.07%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	20.83
P/S	0.3
P/FCF	N/A
P/OCF	4.03
P/B	1.34
P/tB	1.37
EV/EBITDA	7.38

EPS(TTM)-6.18

EYN/A

EPS(NY)0.33

Fwd EY4.8%

FCF(TTM)-0.16

FCFYN/A

OCF(TTM)1.7

OCFY24.81%

SpS22.68

BVpS5.11

TBVpS5.01

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-25.28%
ROE	-129.63%
ROCE	1.52%
ROIC	1.2%
ROICexc	1.26%
ROICexgc	1.27%
OM	1.38%
PM (TTM)	N/A
GM	8.44%
FCFM	N/A

ROA(3y)-2.37%

ROA(5y)-0.88%

ROE(3y)-6.96%

ROE(5y)-2.53%

ROIC(3y)1.78%

ROIC(5y)N/A

ROICexc(3y)1.92%

ROICexc(5y)N/A

ROICexgc(3y)1.93%

ROICexgc(5y)N/A

ROCE(3y)2.25%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y24.16%

GM growth 5Y22.12%

F-Score5

Asset Turnover0.87

Health

		Industry Rank	Sector Rank
Debt/Equity	2.1
Debt/FCF	N/A
Debt/EBITDA	4.68
Cap/Depr	94.04%
Cap/Sales	8.22%
Interest Coverage	0.25
Cash Conversion	74.26%
Profit Quality	N/A
Current Ratio	1.45
Quick Ratio	0.83
Altman-Z	1.17

F-Score5

WACC11.96%

ROIC/WACC0.1

Cap/Depr(3y)90.86%

Cap/Depr(5y)78.47%

Cap/Sales(3y)7.48%

Cap/Sales(5y)6.99%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-194.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-2978.95%

EPS Next Y-8672%

EPS Next 2Y193.19%

EPS Next 3Y194.97%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.9%

Revenue growth 3Y5.02%

Revenue growth 5Y2.64%

Sales Q2Q%-18.27%

Revenue Next Year-10.38%

Revenue Next 2Y-3.16%

Revenue Next 3Y0.3%

Revenue Next 5YN/A

EBIT growth 1Y-53.12%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year366.46%

EBIT Next 3Y108.2%

EBIT Next 5YN/A

FCF growth 1Y-112.86%

FCF growth 3Y-11.5%

FCF growth 5YN/A

OCF growth 1Y-39.58%

OCF growth 3Y-4.42%

OCF growth 5Y37.19%

RAYONIER ADVANCED MATERIALS (RYAM) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens